Article Details

Codexis Announces FDA Orphan Drug and Rare Pediatric Disease Designations for CDX ...

Retrieved on: 2022-01-24 13:24:54

Tags for this article:

Click the tags to see associated articles and topics

Codexis Announces FDA Orphan Drug and Rare Pediatric Disease Designations for CDX .... View article details on hiswai:

Excerpt

24, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up